Upgrade to SI Premium - Free Trial

Eli Lilly & Co. (LLY) Extends Cancer Research Collaboration with Dana-Farber Cancer Institute

July 30, 2018 6:48 AM
Eli Lilly and Company (NYSE: LLY) today announced a three-year extension of its cancer research collaboration with Dana-Farber Cancer Institute ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Management Comments

Next Articles